<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7508045\results\search\testTrace\results.xml">
  <result pre="of clinically detecting and confirming COVID-19 cases, the implementation of" exact="social distancing" post="and hygiene, international air traffic flows, the climate, the"/>
  <result pre="(6.9%) who were initially asymptomatic developed symptoms later [5]. Asymptomatic" exact="infection" post="can occur at any age, but had a higher"/>
  <result pre="infection can occur at any age, but had a higher" exact="prevalence" post="in patients under 45 years old compared with symptomatic"/>
  <result pre="hospitalization due to complications related to COVID-19 (pneumonia, secondary bacterial" exact="infection" post="and respiratory failure) [7]. Because of its high transmission"/>
  <result pre="infected people varies between countries depending on several factors. First," exact="screening" post="strategies vary considerably between countries according to the availability"/>
  <result pre="instance, in western countries, some countries (like France) have recommended" exact="testing" post="only people with mild to severe symptoms, whereas other"/>
  <result pre="2 February and 1 March 2020, the laboratory capacity for" exact="testing" post="for SARS-CoV-2 had increased from two to 34 countries"/>
  <result pre="[22]. However, between 2 February and 15 April 2020, laboratory" exact="testing" post="capacity has increased from two countries (South Africa and"/>
  <result pre="measures, like closing schools, churches, mosques or markets to promote" exact="social distancing" post="or shutting down airports, have been rapidly implemented in"/>
  <result pre="people were estimated to be without handwashing access [31]. Additionally," exact="physical distancing" post="and enhanced hygiene are unlikely to be implementable in"/>
  <result pre="to address Ebola [35,36]. For instance, the surveillance structure and" exact="screening" post="measures in airports developed for Ebola virus disease became"/>
  <result pre="has a lower ACE1 II genotype frequency and a higher" exact="prevalence" post="of infected patients and mortality due to COVID-19 than"/>
  <result pre="a significant positive correlation of the D allele with SARS-CoV-2" exact="infection" post="prevalence and mortality rate in Asian population [79]. The"/>
  <result pre="significant positive correlation of the D allele with SARS-CoV-2 infection" exact="prevalence" post="and mortality rate in Asian population [79]. The DD"/>
  <result pre="implies that these populations might be relatively susceptible to SARS-CoV-2" exact="infection" post="[87]. Cross-immunity to SARS-CoV-2 Protective immune responses to viral"/>
  <result pre="infection [87]. Cross-immunity to SARS-CoV-2 Protective immune responses to viral" exact="infection" post="occur following the combined actions of B cells (humoral"/>
  <result pre="recommended the use of artemisinin-based combination therapy (ACT) in the" exact="treatment" post="of uncomplicated falciparum malaria (artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine or artesunate-mefloquine)"/>
  <result pre="the two most used artemisinin-based combination therapies (ACTs) for the" exact="treatment" post="of uncomplicated falciparum malaria in 2018, especially artemether-lumefantine and"/>
  <result pre="Conclusion The comparison of European and African models of SARS-CoV-2" exact="prevalence" post="could provide important clues to the spread of the"/>
  <result pre="patients diagnosed with COVID-19 in KuwaitEClinicalMedicine24202010044832766546 6YuC.ZhouM.LiuY.GuoT.OuC.YangL.Characteristics of asymptomatics COVID-19" exact="infection" post="and progression: a multicenter, retrospective studyVirulence202010.1080/21505594.2020epub ahead of print"/>
  <result pre="print 7JutzelerC.R.BourguignonL.WeisC.V.TongB.WrongC.RieckB.Comorbidities, clinical signs and symptoms, laboratory findings, imaging features," exact="treatment" post="strategies, and outcomes in adults and pediatric patients with"/>
  <result pre="studyLancet395202087187732087820 16CaboreJ.W.KaramagiH.C.KiprutoH.AsamaniJ.A.DrotiB.SeydiA.B.W.The potential effects of widespread community transmission of SARS-CoV-2" exact="infection" post="in the World Health Organization African Region: a predictive"/>
  <result pre="Africa through 1 June 2020Euro Surveill2520202000543 18NkengasongJ.N.MankoulaW.Looming threat of COVID-19" exact="infection" post="in Africa: act collectively, and fastLancet395202084184232113508 19World Health OrganizationCOVID-19."/>
  <result pre="region4 March 2020External Situation Report 1. Available from:https://apps.who.int/iris/bitstream/handle/10665/331330/SITREP_COVID-19_WHOAFRO_20200304-eng.pdf 20AdebisiY.A.OkeG.I.AdemolaP.S.ChinemelumI.G.Ogun-KolaI.O.Lucera-PrisnoD.E.SARS-CoV-2 diagnostic" exact="testing" post="in Africa: needs and chalengesPan Afr Med J3520204 21KobiaF.GitakaJ.COVID-19:"/>
  <result pre="top ten coldest countriesEur Rev Med Pharmacol Sci2420208232823832767355 68RubinD.HuangJ.FisherB.T.GasparriniA.TamV.SongL.Association of" exact="social distancing," post="population density, and temerature with the instantaneous reproduction number"/>
  <result pre="genotypeGene758202014494432628976 79PatiA.MahtoH.PadhiS.PandaA.K.ACE deletion allele is associated with susceptibility to SARS-CoV-2" exact="infection" post="and mortality rate: an epidemiological study in the Asian"/>
  <result pre="children: what do we know?Arch Pediatr27202011711832253003 106RaymondF.CarbonneauJ.BoucherN.RobitailleL.BoisvertS.WuW.K.Comparison of automated microarray" exact="detection" post="with real-time PCR assays for detection of respiratory viruses"/>
  <result pre="106RaymondF.CarbonneauJ.BoucherN.RobitailleL.BoisvertS.WuW.K.Comparison of automated microarray detection with real-time PCR assays for" exact="detection" post="of respiratory viruses in specimens obtained from childrenJÂ Clin"/>
  <result pre="and epidemiological profiles of hospitalized children with severe acute respiratory" exact="infection" post="in Beijing and Shanghai, ChinaBMC Infect Dis19201972931429710 108GilcaR.CarazoS.AminiR.CharestH.De SerresG.Common"/>
  <result pre="SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid" exact="diagnosis" post="of mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity"/>
  <result pre="pandemic halted by malaria epidemics?Arch Bone Jt Surg8202031932032733987 116PandaA.K.TripathyR.DasB.K.Plasmodium falciparum" exact="infection" post="may protect a population from SARS-CoV-2 infectionJÂ Infect Dis2020jiaa455"/>
  <result pre="20192019Availbale from:https://www.who.int/malaria/publications/world-malaria-report-2019/en/ 118IzouletM.Countries which primarily use antimalarial drugs as COVID-19" exact="treatment" post="see slower dynamic of daily deathsSSRN Electron J2020epub ahead"/>
  <result pre="BALB/c miceAntivir Chem Chemother17200627528417176632 122FanH.H.WangL.Q.LiuW.L.AnX.P.LiuZ.D.HeX.Q.Repurposing of clinically approved drugs for" exact="treatment" post="of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV)"/>
 </snippets>
</snippetsTree>
